Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP Young Israel semaglutide trial in children with obesity
MOH_2023-06-15_012744Phase 3Active, not recruiting
- Sponsor
- Novo Nordisk
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in childhood obesity comparing Semaglutide pediatric arm with Placebo pediatric arm (2 arms). Started Jun 2023; status: active, not recruiting.
02
Drugs
03
Conditions
childhood obesity
Beyond the preview
Go deeper on MOH_2023-06-15_012744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-06-15_012744.